ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03258047
Recruitment Status : Recruiting
First Posted : August 22, 2017
Last Update Posted : February 8, 2018
Sponsor:
Information provided by (Responsible Party):
Wenbin Qian, First Affiliated Hospital of Zhejiang University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 31, 2019
  Estimated Study Completion Date : July 30, 2019